Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Interest Coverage Ratio (2016 - 2025)

Enanta Pharmaceuticals filings provide 9 years of Interest Coverage Ratio readings, the most recent being 3.65 for Q4 2025.

  • On a quarterly basis, Interest Coverage Ratio rose 69.58% to 3.65 in Q4 2025 year-over-year; TTM through Dec 2025 was 8.3, a 28.84% increase, with the full-year FY2025 number at 11.11, changed 0.11% from a year prior.
  • Interest Coverage Ratio hit 3.65 in Q4 2025 for Enanta Pharmaceuticals, up from 7.7 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 3.65 in Q4 2025 to a low of 18.38 in Q2 2023.
  • Median Interest Coverage Ratio over the past 3 years was 11.57 (2024), compared with a mean of 11.12.
  • Biggest five-year swings in Interest Coverage Ratio: dropped 18.36% in 2024 and later surged 69.58% in 2025.
  • Enanta Pharmaceuticals' Interest Coverage Ratio stood at 10.14 in 2023, then fell by 18.36% to 12.0 in 2024, then surged by 69.58% to 3.65 in 2025.
  • The last three reported values for Interest Coverage Ratio were 3.65 (Q4 2025), 7.7 (Q3 2025), and 11.68 (Q2 2025) per Business Quant data.